{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T07:00:41Z","timestamp":1762326041514,"version":"3.28.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioData Mining"],"DOI":"10.1186\/s13040-024-00404-x","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T15:33:15Z","timestamp":1731598395000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Transcriptome-based network analysis related to regulatory T cells infiltration identified RCN1 as a potential biomarker for prognosis in clear cell renal cell carcinoma"],"prefix":"10.1186","volume":"17","author":[{"given":"Yang","family":"Qixin","sequence":"first","affiliation":[]},{"given":"Huang","family":"Jing","sequence":"additional","affiliation":[]},{"given":"He","family":"Jiang","sequence":"additional","affiliation":[]},{"given":"Liu","family":"Xueyang","sequence":"additional","affiliation":[]},{"given":"Yu","family":"Lu","sequence":"additional","affiliation":[]},{"given":"Li","family":"Yuehua","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"issue":"10021","key":"404_CR1","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S0140-6736(15)00046-X","volume":"387","author":"U Capitanio","year":"2016","unstructured":"Capitanio U, Montorsi F. Renal cancer. Lancet. 2016;387(10021):894\u2013906.","journal-title":"Lancet"},{"issue":"9669","key":"404_CR2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","volume":"373","author":"BI Rini","year":"2009","unstructured":"Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet. 2009;373(9669):1119\u201332.","journal-title":"Lancet"},{"issue":"4","key":"404_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMra1601333","volume":"376","author":"TK Choueiri","year":"2017","unstructured":"Choueiri TK, Motzer RJ. Systemic Therapy for Metastatic Renal-Cell Carcinoma. N Engl J Med. 2017;376(4):354\u201366.","journal-title":"N Engl J Med"},{"issue":"6","key":"404_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3322\/caac.21411","volume":"67","author":"PC Barata","year":"2017","unstructured":"Barata PC, Rini BI. Treatment of renal cell carcinoma: Current status and future directions. CA Cancer J Clin. 2017;67(6):507\u201324.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"404_CR5","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S1470-2045(09)70162-7","volume":"10","author":"ME Gore","year":"2009","unstructured":"Gore ME, et al. Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial. Lancet Oncol. 2009;10(8):757\u201363.","journal-title":"Lancet Oncol"},{"issue":"10","key":"404_CR6","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S1470-2045(09)70240-2","volume":"10","author":"BI Rini","year":"2009","unstructured":"Rini BI, Atkins MB. Resistance to targeted therapy in renal-cell carcinoma. Lancet Oncol. 2009;10(10):992\u20131000.","journal-title":"Lancet Oncol"},{"issue":"5","key":"404_CR7","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/canjclin.46.5.284","volume":"46","author":"MH Sokoloff","year":"1996","unstructured":"Sokoloff MH, et al. Current management of renal cell carcinoma. CA Cancer J Clin. 1996;46(5):284\u2013302.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"404_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41571-024-00870-6","volume":"21","author":"S Kumagai","year":"2024","unstructured":"Kumagai S, Itahashi K, Nishikawa H. Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine. Nat Rev Clin Oncol. 2024;21(5):337\u201353.","journal-title":"Nat Rev Clin Oncol."},{"issue":"4","key":"404_CR9","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1158\/1078-0432.CCR-23-2274","volume":"30","author":"T Denize","year":"2024","unstructured":"Denize T, et al. PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients. Clin Cancer Res. 2024;30(4):803\u201313.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"404_CR10","first-page":"e461","volume":"5","author":"W Xu","year":"2024","unstructured":"Xu W, et al. Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma. MedComm\u00a0(2020). 2024;5(1):e461.","journal-title":"MedComm\u00a0(2020)"},{"issue":"9","key":"404_CR11","doi-asserted-by":"publisher","first-page":"7946","DOI":"10.3390\/ijms24097946","volume":"24","author":"CU Monjaras-Avila","year":"2023","unstructured":"Monjaras-Avila CU, et al. The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma. Int J Mol Sci. 2023;24(9):7946.","journal-title":"Int J Mol Sci."},{"issue":"1","key":"404_CR12","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1038\/s41467-021-26091-4","volume":"12","author":"MC Kim","year":"2021","unstructured":"Kim MC, et al. CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cells. Nat Commun. 2021;12(1):5764.","journal-title":"Nat Commun"},{"issue":"1","key":"404_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13046-024-02960-w","volume":"43","author":"W Yang","year":"2024","unstructured":"Yang W, et al. T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution. J Exp Clin Cancer Res. 2024;43(1):38.","journal-title":"J Exp Clin Cancer Res"},{"issue":"36","key":"404_CR14","doi-asserted-by":"publisher","first-page":"JCO2018792259","DOI":"10.1200\/JCO.2018.79.2259","volume":"36","author":"S Signoretti","year":"2018","unstructured":"Signoretti S, et al. Renal Cell Carcinoma in the Era of Precision Medicine: From Molecular Pathology to Tissue-Based Biomarkers. J Clin Oncol. 2018;36(36):JCO2018792259.","journal-title":"J Clin Oncol"},{"key":"404_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.941835","volume":"13","author":"C Climent","year":"2023","unstructured":"Climent C, et al. The role of immunotherapy in non-clear cell renal cell carcinoma. Front Oncol. 2023;13: 941835.","journal-title":"Front Oncol"},{"issue":"10","key":"404_CR16","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1158\/1078-0432.CCR-20-4119","volume":"27","author":"E Marostica","year":"2021","unstructured":"Marostica E, et al. Development of a Histopathology Informatics Pipeline for Classification and Prediction of Clinical Outcomes in Subtypes of Renal Cell Carcinoma. Clin Cancer Res. 2021;27(10):2868\u201378.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"404_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12929-023-00915-5","volume":"30","author":"Z Wu","year":"2023","unstructured":"Wu Z, et al. A transcriptomic pan-cancer signature for survival prognostication and prediction of immunotherapy response based on endothelial senescence. J Biomed Sci. 2023;30(1):21.","journal-title":"J Biomed Sci"},{"issue":"1","key":"404_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13073-022-01050-w","volume":"14","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, et al. Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response. Genome Med. 2022;14(1):45.","journal-title":"Genome Med"},{"issue":"1","key":"404_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13578-022-00948-7","volume":"12","author":"A Jiang","year":"2022","unstructured":"Jiang A, et al. A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma. Cell Biosci. 2022;12(1):209.","journal-title":"Cell Biosci"},{"issue":"1","key":"404_CR20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/hep.30816","volume":"71","author":"CJ O'Rourke","year":"2020","unstructured":"O\u2019Rourke CJ, et al. Identification of a Pan-Gamma-Secretase Inhibitor Response Signature for Notch-Driven Cholangiocarcinoma. Hepatology. 2020;71(1):196\u2013213.","journal-title":"Hepatology"},{"issue":"1","key":"404_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41698-024-00532-x","volume":"8","author":"G Margue","year":"2024","unstructured":"Margue G, et al. UroPredict: Machine learning model on real-world data for prediction of kidney cancer recurrence (UroCCR-120). NPJ Precis Oncol. 2024;8(1):45.","journal-title":"NPJ Precis Oncol"},{"key":"404_CR22","doi-asserted-by":"publisher","first-page":"1272108","DOI":"10.3389\/fimmu.2023.1272108","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. A pan-cancer analysis of the prognostic implication and oncogenic role of tubulin epsilon and delta complex 2 (TEDC2) in human tumors. Front Immunol. 2023;14:1272108.","journal-title":"Front Immunol"},{"issue":"1","key":"404_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12967-022-03287-w","volume":"20","author":"J Wang","year":"2022","unstructured":"Wang J, et al. A web-based prediction model for overall survival of elderly patients with early renal cell carcinoma: a population-based study. J Transl Med. 2022;20(1):90.","journal-title":"J Transl Med"},{"issue":"1","key":"404_CR24","doi-asserted-by":"publisher","first-page":"22340","DOI":"10.1038\/s41598-023-49219-6","volume":"13","author":"M Wei","year":"2023","unstructured":"Wei M, et al. Prognostic and risk factor analysis of cancer patients after unplanned ICU admission: a real-world multicenter study. Sci Rep. 2023;13(1):22340.","journal-title":"Sci Rep"},{"issue":"3","key":"404_CR25","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/bies.200800186","volume":"31","author":"B Honor\u00e9","year":"2009","unstructured":"Honor\u00e9 B. The rapidly expanding CREC protein family: members, localization, function, and role in disease. BioEssays. 2009;31(3):262\u201377.","journal-title":"BioEssays"},{"key":"404_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.736947","volume":"8","author":"W Lu","year":"2021","unstructured":"Lu W, et al. Integrative Analyses and Verification of the Expression and Prognostic Significance for RCN1 in Glioblastoma Multiforme. Front Mol Biosci. 2021;8: 736947.","journal-title":"Front Mol Biosci"},{"issue":"24","key":"404_CR27","doi-asserted-by":"publisher","first-page":"11198","DOI":"10.1111\/jcmm.17040","volume":"25","author":"H Fu","year":"2021","unstructured":"Fu H, et al. Reticulocalbin 1 is required for proliferation and migration of non-small cell lung cancer cells regulated by osteoblast-conditioned medium. J Cell Mol Med. 2021;25(24):11198\u2013211.","journal-title":"J Cell Mol Med"},{"key":"404_CR28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jprot.2013.07.018","volume":"91","author":"G Giribaldi","year":"2013","unstructured":"Giribaldi G, et al. Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma. J Proteomics. 2013;91:385\u201392.","journal-title":"J Proteomics"},{"issue":"1","key":"404_CR29","doi-asserted-by":"publisher","first-page":"21488","DOI":"10.1038\/s41598-023-48801-2","volume":"13","author":"H Liu","year":"2023","unstructured":"Liu H, et al. RCN1 deficiency inhibits oral squamous cell carcinoma progression and THP-1 macrophage M2 polarization. Sci Rep. 2023;13(1):21488.","journal-title":"Sci Rep"},{"key":"404_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2014.08.007","volume":"90","author":"EW May","year":"2014","unstructured":"May EW, et al. Identification of up- and down-regulated proteins in doxorubicin-resistant uterine cancer cells: reticulocalbin-1 plays a key role in the development of doxorubicin-associated resistance. Pharmacol Res. 2014;90:1\u201317.","journal-title":"Pharmacol Res"},{"issue":"1","key":"404_CR31","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41420-021-00696-6","volume":"7","author":"JW Wang","year":"2021","unstructured":"Wang JW, et al. RCN1 induces sorafenib resistance and malignancy in hepatocellular carcinoma by activating c-MYC signaling via the IRE1\u03b1-XBP1s pathway. Cell Death Discov. 2021;7(1):298.","journal-title":"Cell Death Discov"},{"issue":"4","key":"404_CR32","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/cas.13541","volume":"109","author":"X Liu","year":"2018","unstructured":"Liu X, et al. Downregulation of reticulocalbin-1 differentially facilitates apoptosis and necroptosis in human prostate cancer cells. Cancer Sci. 2018;109(4):1147\u201357.","journal-title":"Cancer Sci"},{"issue":"8","key":"404_CR33","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ng.2699","volume":"45","author":"Y Sato","year":"2013","unstructured":"Sato Y, et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet. 2013;45(8):860\u20137.","journal-title":"Nat Genet"},{"issue":"6","key":"404_CR34","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s41591-020-0839-y","volume":"26","author":"DA Braun","year":"2020","unstructured":"Braun DA, et al. Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma. Nat Med. 2020;26(6):909\u201318.","journal-title":"Nat Med"},{"issue":"5","key":"404_CR35","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ccell.2021.02.015","volume":"39","author":"K Bi","year":"2021","unstructured":"Bi K, et al. Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma. Cancer Cell. 2021;39(5):649-661 e5.","journal-title":"Cancer Cell"},{"issue":"1","key":"404_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/d41573-023-00186-7","volume":"23","author":"J Tur","year":"2024","unstructured":"Tur J, Webster RM. The renal cell carcinoma drug market. Nat Rev Drug Discov. 2024;23(1):16\u20137.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"404_CR37","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41591-021-01320-x","volume":"27","author":"T Zhang","year":"2021","unstructured":"Zhang T, George DJ. Immunotherapy and targeted-therapy combinations mark a new era of kidney cancer treatment. Nat Med. 2021;27(4):586\u20138.","journal-title":"Nat Med"},{"issue":"3","key":"404_CR38","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41590-024-01755-7","volume":"25","author":"T Wertheimer","year":"2024","unstructured":"Wertheimer T, et al. IL-23 stabilizes an effector T(reg) cell program in the tumor microenvironment. Nat Immunol. 2024;25(3):512\u201324.","journal-title":"Nat Immunol"},{"issue":"7","key":"404_CR39","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1111\/cas.14069","volume":"110","author":"Y Ohue","year":"2019","unstructured":"Ohue Y, Nishikawa H. Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target? Cancer Sci. 2019;110(7):2080\u20139.","journal-title":"Cancer Sci"},{"key":"404_CR40","doi-asserted-by":"publisher","first-page":"15179","DOI":"10.1038\/srep15179","volume":"5","author":"B Shang","year":"2015","unstructured":"Shang B, et al. Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis. Sci Rep. 2015;5:15179.","journal-title":"Sci Rep"},{"issue":"1","key":"404_CR41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943-020-01234-1","volume":"19","author":"C Li","year":"2020","unstructured":"Li C, et al. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects. Mol Cancer. 2020;19(1):116.","journal-title":"Mol Cancer"},{"issue":"11","key":"404_CR42","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1016\/j.cell.2021.04.038","volume":"184","author":"A Obradovic","year":"2021","unstructured":"Obradovic A, et al. Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages. Cell. 2021;184(11):2988-3005 e16.","journal-title":"Cell"},{"issue":"15","key":"404_CR43","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1158\/1078-0432.CCR-16-2848","volume":"23","author":"NA Giraldo","year":"2017","unstructured":"Giraldo NA, et al. Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma. Clin Cancer Res. 2017;23(15):4416\u201328.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"404_CR44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13059-016-1092-z","volume":"17","author":"Y \u015eenbabao\u011flu","year":"2016","unstructured":"\u015eenbabao\u011flu Y, et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol. 2016;17(1):231.","journal-title":"Genome Biol"},{"issue":"20","key":"404_CR45","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1093\/bioinformatics\/btt425","volume":"29","author":"EF Lock","year":"2013","unstructured":"Lock EF, Dunson DB. Bayesian consensus clustering. Bioinformatics. 2013;29(20):2610\u20136.","journal-title":"Bioinformatics"},{"issue":"1","key":"404_CR46","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12859-021-04279-1","volume":"22","author":"G Bri\u00e8re","year":"2021","unstructured":"Bri\u00e8re G, et al. Consensus clustering applied to multi-omics disease subtyping. BMC Bioinformatics. 2021;22(1):361.","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"404_CR47","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1158\/1078-0432.CCR-14-1128","volume":"21","author":"B Beuselinck","year":"2015","unstructured":"Beuselinck B, et al. Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting. Clin Cancer Res. 2015;21(6):1329\u201339.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"404_CR48","doi-asserted-by":"publisher","first-page":"14588","DOI":"10.1038\/s41598-022-18620-y","volume":"12","author":"GA Puzanov","year":"2022","unstructured":"Puzanov GA. Identification of key genes of the ccRCC subtype with poor prognosis. Sci Rep. 2022;12(1):14588.","journal-title":"Sci Rep"},{"issue":"3","key":"404_CR49","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/s41418-020-00635-5","volume":"28","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. CHIP-mediated CIB1 ubiquitination regulated epithelial-mesenchymal transition and tumor metastasis in lung adenocarcinoma. Cell Death Differ. 2021;28(3):1026\u201340.","journal-title":"Cell Death Differ"},{"issue":"26","key":"404_CR50","doi-asserted-by":"publisher","first-page":"p. eabl8247","DOI":"10.1126\/sciadv.abl8247","volume":"8","author":"P Ji","year":"2022","unstructured":"Ji P, et al. In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer. Sci Adv. 2022;8(26):eabl8247.","journal-title":"Sci Adv"},{"issue":"12","key":"404_CR51","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1052935","volume":"4","author":"SD Desai","year":"2015","unstructured":"Desai SD. ISG15: A double edged sword in cancer. Oncoimmunology. 2015;4(12): e1052935.","journal-title":"Oncoimmunology"},{"key":"404_CR52","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fcell.2016.00020","volume":"4","author":"JJ Kim","year":"2016","unstructured":"Kim JJ, Lipatova Z, Segev N. TRAPP Complexes in Secretion and Autophagy. Front Cell Dev Biol. 2016;4:20.","journal-title":"Front Cell Dev Biol"},{"issue":"47","key":"404_CR53","doi-asserted-by":"publisher","first-page":"19392","DOI":"10.1074\/jbc.M117.802884","volume":"292","author":"Y Kitai","year":"2017","unstructured":"Kitai Y, et al. STAP-2 protein promotes prostate cancer growth by enhancing epidermal growth factor receptor stabilization. J Biol Chem. 2017;292(47):19392\u20139.","journal-title":"J Biol Chem"},{"issue":"45","key":"404_CR54","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1038\/onc.2015.32","volume":"34","author":"X Sun","year":"2015","unstructured":"Sun X, et al. HSPB1 as a novel regulator of ferroptotic cancer cell death. Oncogene. 2015;34(45):5617\u201325.","journal-title":"Oncogene"},{"issue":"4","key":"404_CR55","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0006-291X(03)01515-8","volume":"311","author":"Z Hilioti","year":"2003","unstructured":"Hilioti Z, Cunningham KW. The RCN family of calcineurin regulators. Biochem Biophys Res Commun. 2003;311(4):1089\u201393.","journal-title":"Biochem Biophys Res Commun"},{"key":"404_CR56","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.humpath.2018.08.014","volume":"83","author":"X Chen","year":"2019","unstructured":"Chen X, et al. Overexpression of RCN1 correlates with poor prognosis and progression in non-small cell lung cancer. Hum Pathol. 2019;83:140\u20138.","journal-title":"Hum Pathol"},{"issue":"1","key":"404_CR57","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1186\/s12885-023-11303-5","volume":"23","author":"J Ning","year":"2023","unstructured":"Ning J, et al. Expression signature and prognostic value of CREC gene family in human colorectal cancer. BMC Cancer. 2023;23(1):878.","journal-title":"BMC Cancer"},{"issue":"8","key":"404_CR58","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.4049\/jimmunol.1102152","volume":"189","author":"S Choi","year":"2012","unstructured":"Choi S, et al. Role of macrophage migration inhibitory factor in the regulatory T cell response of tumor-bearing mice. J Immunol. 2012;189(8):3905\u201313.","journal-title":"J Immunol"}],"container-title":["BioData Mining"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-024-00404-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13040-024-00404-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-024-00404-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T16:04:30Z","timestamp":1731600270000},"score":1,"resource":{"primary":{"URL":"https:\/\/biodatamining.biomedcentral.com\/articles\/10.1186\/s13040-024-00404-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["404"],"URL":"https:\/\/doi.org\/10.1186\/s13040-024-00404-x","relation":{},"ISSN":["1756-0381"],"issn-type":[{"value":"1756-0381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"29 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}